Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception

Prostaglandins and Other Lipid Mediators

Volumn 96, Issue 1-4, 2011, Pages 76-83

  Wagner, Karen ^a   Inceoglu, Bora ^a   Hammock, Bruce D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allodynia; Arachidonic acid; Cannabinoid; CNS; Epoxyeicosatrienoic acid; Epoxygenated fatty acids; Hyperalgesia; Nociception; Opioid

Indexed keywords

CYTOCHROME P450; EPOXIDE HYDROLASE; EPOXYGENATED FATTY ACID; FATTY ACID; GLYCEROPHOSPHOLIPID; LEUKOTRIENE; LIPOXYGENASE; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN SYNTHASE; PROSTANOID; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 4;

ALLODYNIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIPYRETIC ACTIVITY; CALCIUM TRANSPORT; CELL MEMBRANE; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; HALF LIFE TIME; LIPID DEGRADATION; LIPID TRANSPORT; MEDIATOR RELEASE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PROSTAGLANDIN RELEASE; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; REVIEW; THERMOREGULATION;

8,11,14-EICOSATRIENOIC ACID; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTI-INFLAMMATORY AGENTS; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ENZYME INHIBITORS; EPOXIDE HYDROLASES; HUMANS; HYPERALGESIA; INFLAMMATION; MICE; MICE, KNOCKOUT; NERVOUS SYSTEM; NOCICEPTION; PAIN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 81155139719     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2011.08.001     Document Type: Review

References (76)

1. M. Murakami Lipid mediators in life science Exp Anim 60 1 2011 7 20
2. S. Chalon, S. Vancassel, and L. Zimmer Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission Lipids 36 9 2001 937 944 (Pubitemid 33065195)
3. M. Haag Essential fatty acids and the brain Can J Psychiatry 48 3 2003 195 203 (Pubitemid 36603376)
4. S.R. Wassall, M.R. Brzustowicz, and S.R. Shaikh Order from disorder: corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation Chem Phys Lipids 132 1 2004 79 88 (Pubitemid 39458322)
5. S.I. Rapoport, J.S. Rao, and M. Igarashi Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver Prostaglandins Leukot Essent Fatty Acids 77 5-6 2007 251 261 (Pubitemid 350214520)
6. J. Wang, and N. Ueda Biology of endocannabinoid synthesis system Prostaglandins Other Lipid Mediat 89 3-4 2009 112 119
7. K. Mayurasakorn, J.J. Williams, and V.S. Ten Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia Curr Opin Clin Nutr Metab Care 14 2 2011 158 167
8. A.D. Purdon, and S.I. Rapoport 4.6 Energy Consumption by Phospholipid Metabolism in Mammalian Brain A. Lajtha, G.E. Gibson, G.A. Dienel, Handbook of Neurochemistry and Molecular Neurobiology 2007 Springer US 401 427
9. G. Burdge Alpha-linolenic acid metabolism in men and women: nutritional and biological implications Curr Opin Clin Nutr Metab Care 7 2 2004 137 144 (Pubitemid 40340675)
10. S.M. Innis Dietary omega 3 fatty acids and the developing brain Brain Res 1237 2008 35 43
11. K. Bernstrom, K. Kayganich, and R.C. Murphy Incorporation and distribution of epoxyeicosatrienoic acids into cellular phospholipids J Biol Chem 267 6 1992 3686 3690
12. M. Tomita-Yamaguchi, J.F. Babich, and R.C. Baker Incorporation: distribution, and turnover of arachidonic acid within membrane phospholipids of B220+ T cells from autoimmune-prone MRL-lpr/lpr mice J Exp Med 171 3 1990 787 800 (Pubitemid 20088982)
13. A.A. Spector, and A.W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol 292 3 2007 C996 C1012
14. T. Shimizu, and L.S. Wolfe Arachidonic acid cascade and signal transduction J Neurochem 55 1 1990 1 15
15. A. Konkel, and W.H. Schunck Role of cytochrome P450 enzymes in the bioactivation of polyunsaturated fatty acids Biochim Biophys Acta 1814 1 2011 210 222
16. M. Fer, Y. Dreano, and D. Lucas Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450 Arch Biochem Biophys 471 2 2008 116 125
17. J.H. Capdevila, J.R. Falck, and R.C. Harris Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase J Lipid Res 41 2 2000 163 181 (Pubitemid 30117856)
18. A.A. Spector Arachidonic acid cytochrome P450 epoxygenase pathway J Lipid Res 50 Suppl 2009 S52 S56
19. J.D. Imig, and B.D. Hammock Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nat Rev Drug Discov 8 10 2009 794 805
20. P. McLennan, P. Howe, and M. Abeywardena The cardiovascular protective role of docosahexaenoic acid Eur J Pharmacol 300 1-2 1996 83 89 (Pubitemid 26130477)
21. N. Chiamvimonvat, C.M. Ho, and H.J. Tsai The soluble epoxide hydrolase as a pharmaceutical target for hypertension J Cardiovasc Pharmacol 50 3 2007 225 237 (Pubitemid 47428969)
22. B. Inceoglu, S.L. Jinks, and A. Ulu Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathways Proc Natl Acad Sci USA 105 48 2008 18901 18906
23. A. Marowsky, J. Burgener, and J.R. Falck Distribution of soluble and microsomal epoxide hydrolase in the mouse brain and its contribution to cerebral epoxyeicosatrienoic acid metabolism Neuroscience 163 2 2009 646 661
24. R.A. Bianco, K. Agassandian, and M.D. Cassell Characterization of transgenic mice with neuron-specific expression of soluble epoxide hydrolase Brain Res 1291 2009 60 72
25. A.E. Enayetallah, R.A. French, and M.S. Thibodeau Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8: 2C9, and 2J2 in human tissues J Histochem Cytochem 52 4 2004 447 454 (Pubitemid 38420379)
26. N. Chacos, J. Capdevila, and J.R. Falck The reaction of arachidonic acid epoxides (epoxyeicosatrienoic acids) with a cytosolic epoxide hydrolase Arch Biochem Biophys 223 2 1983 639 648 (Pubitemid 13103208)
27. J.W. Newman, C. Morisseau, and B.D. Hammock Epoxide hydrolases: their roles and interactions with lipid metabolism Prog Lipid Res 44 1 2005 1 51 (Pubitemid 40313218)
28. A. Luria, S.M. Weldon, and A.K. Kabcenell Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice J Biol Chem 282 5 2007 2891 2898 (Pubitemid 47084334)
29. C. Morisseau, B. Inceoglu, and K. Schmelzer Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids J Lipid Res 51 12 2010 3481 3490
30. D.C. Zeldin Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 39 2001 36059 36062
31. M.F. Moghaddam, D.F. Grant, and J.M. Cheek Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase Nat Med 3 5 1997 562 566 (Pubitemid 27198657)
32. M.W. Buczynski, C.I. Svensson, and D.S. Dumlao Inflammatory hyperalgesia induces essential bioactive lipid production in the spinal cord J Neurochem 114 4 2010 981 993
33. S.C. Amruthesh, J.R. Falck, and E.F. Ellis Brain synthesis and cerebrovascular action of epoxygenase metabolites of arachidonic acid J Neurochem 58 2 1992 503 510
34. B. Inceoglu, S.L. Jinks, and K.R. Schmelzer Inhibition of soluble epoxide hydrolase reduces LPS-induced thermal hyperalgesia and mechanical allodynia in a rat model of inflammatory pain Life Sci 79 24 2006 2311 2319 (Pubitemid 44666069)
35. E. Abdu, D.A. Bruun, and D. Yang Epoxyeicosatrienoic acids enhance axonal growth in primary sensory and cortical neuronal cell cultures J Neurochem 117 4 2010 632 642
36. S.H. Ferreira, B.B. Lorenzetti, and F.M. Correa Central and peripheral antialgesic action of aspirin-like drugs Eur J Pharmacol 53 1 1978 39 48
37. J.D. Levine, D. Lam, and Y.O. Taiwo Hyperalgesic properties of 15-lipoxygenase products of arachidonic acid Proc Natl Acad Sci USA 83 14 1986 5331 5334 (Pubitemid 16051369)
38. K.A. Park, and M.R. Vasko Lipid mediators of sensitivity in sensory neurons Trends Pharmacol Sci 26 11 2005 571 577 (Pubitemid 41505225)
39. S. Bang, S. Yoo, and U. Oh Endogenous lipid-derived ligands for sensory TRP ion channels and their pain modulation Arch Pharm Res 33 10 2010 1509 1520
40. W.B. Campbell, and I. Fleming Epoxyeicosatrienoic acids and endothelium-dependent responses Pflugers Arch 459 6 2010 881 895
41. Y. Sugimoto, and S. Narumiya Prostaglandin E receptors J Biol Chem 282 16 2007 11613 11617 (Pubitemid 47100657)
42. S. Narumiya, Y. Sugimoto, and F. Ushikubi Prostanoid receptors: structures, properties, and functions Physiol Rev 79 4 1999 1193 1226 (Pubitemid 29473315)
43. D. Piomelli The molecular logic of endocannabinoid signalling Nat Rev Neurosci 4 11 2003 873 884 (Pubitemid 37351427)
44. W. Yang, V.R. Tuniki, and S. Anjaiah Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist: 20-125i-14,15-epoxyeicosa-8(Z)-enoic acid J Pharmacol Exp Ther 324 3 2008 1019 1027 (Pubitemid 351397827)
45. J.R. Falck, U.M. Krishna, and Y.K. Reddy Comparison of vasodilatory properties of 14,15-EET analogs: structural requirements for dilation Am J Physiol Heart Circ Physiol 284 1 2003 H337 H349
46. K.M. Gauthier, C. Deeter, and U.M. Krishna 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries Circ Res 90 9 2002 1028 1036 (Pubitemid 34633870)
47. H. Watanabe, J. Vriens, and J. Prenen Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels Nature 424 6947 2003 434 438 (Pubitemid 36917492)
48. S. Earley, T.J. Heppner, and M.T. Nelson TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BKCa channels Circ Res 97 12 2005 1270 1279
49. I. Fleming, A. Rueben, and R. Popp Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells Arterioscler Thromb Vasc Biol 27 12 2007 2612 2618 (Pubitemid 350158913)
50. D. Ye, W. Zhou, and H.C. Lee Activation of rat mesenteric arterial KATP channels by 11,12-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol 288 1 2005 H358 H364
51. D. Ye, W. Zhou, and T. Lu Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol Heart Circ Physiol 290 4 2006 H1326 H1336
52. T. Nakashima, Y. Harada, and S. Miyata Inhibitors of cytochrome P-450 augment fever induced by interleukin-1 beta Am J Physiol 271 5 Pt 2 1996 R1274 R1279
53. K. Node, Y. Huo, and X. Ruan Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 5431 1999 1276 1279 (Pubitemid 29398616)
54. K.R. Schmelzer, L. Kubala, and J.W. Newman Soluble epoxide hydrolase is a therapeutic target for acute inflammation Proc Natl Acad Sci USA 102 28 2005 9772 9777 (Pubitemid 40993644)
55. K.R. Schmelzer, B. Inceoglu, and L. Kubala Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors Proc Natl Acad Sci USA 103 37 2006 13646 13651 (Pubitemid 44413961)
56. S.A. Kanaan, N.E. Saade, and J.J. Haddad Endotoxin-induced local inflammation and hyperalgesia in rats and mice: a new model for inflammatory pain Pain 66 2-3 1996 373 379 (Pubitemid 26284008)
57. B. Inceoglu, K.R. Schmelzer, and C. Morisseau Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) Prostaglandins Other Lipid Mediat 82 1-4 2007 42 49 (Pubitemid 44880165)
58. J.Y. Liu, J. Yang, and B. Inceoglu Inhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine model Biochem Pharmacol 79 6 2010 880 887
59. S.H. Hwang, K. Wagner, and C. Morisseau Synthesis and structure-activity relationship studies of urea-containing pyrazoles as dual inhibitors of cyclooxygenase-2 and soluble epoxide hydrolase J Med Chem 54 8 2011 3037 3050
60. B. Inceoglu, K. Wagner, and N.H. Schebb Analgesia mediated by soluble epoxide hydrolase inhibitors is dependent on cAMP Proc Natl Acad Sci USA 108 12 2011 5093 5097
61. S.G. Khasar, T. Ho, and P.G. Green Comparison of prostaglandin E1- and prostaglandin E2-induced hyperalgesia in the rat Neuroscience 62 2 1994 345 350
62. H.U. Zeilhofer Prostanoids in nociception and pain Biochem Pharmacol 73 2 2007 165 174 (Pubitemid 44855718)
63. W.B. Campbell, and J.R. Falck Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 3 2007 590 596
64. M.A. Carroll, A.B. Doumad, and J. Li Adenosine2A receptor vasodilation of rat preglomerular microvessels is mediated by EETs that activate the cAMP/PKA pathway Am J Physiol Renal Physiol 291 1 2006 F155 F161
65. M. Terashvili, L.F. Tseng, and H.E. Wu Antinociception produced by 14,15-epoxyeicosatrienoic acid is mediated by the activation of beta-endorphin and met-enkephalin in the rat ventrolateral periaqueductal gray J Pharmacol Exp Ther 326 2 2008 614 622
66. J.L. Conroy, C. Fang, and J. Gu Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling Nat Neurosci 13 3 2010 284 286
67. L.B. Hough, J.W. Nalwalk, and J. Yang Brain P450 epoxygenase activity is required for the antinociceptive effects of improgan, a nonopioid analgesic Pain 152 4 2011 878 887
68. M.M. Heinricher, J.J. Maire, and D. Lee Physiological basis for inhibition of morphine and improgan antinociception by CC12: a P450 epoxygenase inhibitor J Neurophysiol 104 6 2010 3222 3230
69. A.C. Howlett, F. Barth, and T.I. Bonner International Union of Pharmacology. XXVII. Classification of cannabinoid receptors Pharmacol Rev 54 2 2002 161 202 (Pubitemid 34575709)
70. D. Piomelli, A. Giuffrida, and A. Calignano The endocannabinoid system as a target for therapeutic drugs Trends Pharmacol Sci 21 6 2000 218 224 (Pubitemid 30331091)
71. K.R. Kozak, and L.J. Marnett Oxidative metabolism of endocannabinoids Prostaglandins Leukot Essent Fatty Acids 66 2-3 2002 211 220 (Pubitemid 34743596)
72. N.T. Snider, J.A. Nast, and L.A. Tesmer A cytochrome P450-derived epoxygenated metabolite of anandamide is a potent cannabinoid receptor 2-selective agonist Mol Pharmacol 75 4 2009 965 972
73. C. Sridar, N.T. Snider, and P.F. Hollenberg Anandamide oxidation by wild type and polymorphically expressed CYP2B6 and CYP2D6 Drug Metab Dispos 39 5 2011 782 788
74. N.T. Snider, M.J. Sikora, and C. Sridar The endocannabinoid anandamide is a substrate for the human polymorphic cytochrome P450 2D6 J Pharmacol Exp Ther 327 2 2008 538 545
75. T.P. Malan Jr. , M.M. Ibrahim, and J. Lai CB2 cannabinoid receptor agonists: pain relief without psychoactive effects? Curr Opin Pharmacol 3 1 2003 62 67 (Pubitemid 36131328)
76. H. Cadas, S. Gaillet, and M. Beltramo Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP J Neurosci 16 12 1996 3934 3942 (Pubitemid 26176057)